(2 mg/ml, Cladribine, 2-chloro-2'-deoxyadenosine, 2-CdA)

Cladribine is an antineoplastic agent of the following pharmacotherapeutic group: antineoplastic agents, antimetabolites, purine analogues (ATC-Code: L01BB04).

Litak® is a solution for injection that contains the active substance cladribine to treat rare forms of leukemia or lymphoma.

 Litak (cladribine)
In addition to all member states of the European Union Litak® is also registered in the following countries: